Table 1 Baseline characteristics of the study participants

From: Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial

Characteristics

Vitamin D-group Mean±s.d.

Placebo group Mean±s.d.

Subjects (Male)

45 (9)

42(7)

Age (years)

49±8

48±8

Body mass index (kg/m2)

37.9±6.1

37.6±7.7

Fitzpatrick skin score grade IV & V (%)

78

90

Oral anti-diabetic drugs (%)

69

50

Oral anti-diabetic drugs+insulin (%)

31

50

T2D duration of diagnosis (years)

9.5±6.2

9.1±5.5

Exposure to direct sunlight <15 min/day (%)

60

74

S-25(OH) vitamin D (nmol/l)

28.5±9.2

30.5±11.2

B-HbA1c (%)

8.3±1.3

8.3±1.9

  1. Abbreviations: s-25(OH)vitamin D, serum 25-hydroxy vitamin D; T2D, type 2 diabetes mellitus.
  2. Values are Mean±s.d.
Back to article page